1. | christianminitru | |
2. | hotbrisk | |
3. | jameskass | |
4. | jlkpls | |
5. | titanrep20 |
1. | christianminitru | |
2. | hotbrisk | |
3. | jameskass | |
4. | jlkpls | |
5. | titanrep20 |
1. | jlkpls 11/15/2018 Auris Medical Reports Third Quarter 2018 Financial Results and Provides Business Update |
2. | hotbrisk 03/13/2018 Auris Medical Provides Business Update |
3. | jameskass 05/06/2018 Auris Medical Announces Publication Related to AM-111 in Peer-Reviewed Scientific Journal |
4. | titanrep20 07/03/2018 Auris Medical Announces Publication Confirming Dose-Dependent Effects of Betahistine and Relationship to Bioavailability in Cat Model of Acute Vertigo |
5. | jameskass 01/30/2018 Raises this low are killers |
6. | christianminitru 02/07/2018 Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine |
7. | hotbrisk 05/06/2018 Turn around time |
8. | christianminitru 01/29/2018 Auris Medical Announces Pricing of $5.5 Million Registered Direct Offering |
9. | dolphinprincess7 11/20/2018 Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program in Olanzapine-Induced Weight Gain |
10. | hotbrisk 01/30/2018 Get the word out! Severely undervalued, need above $1 |